Disseminated Cryptococcal Disease with Skeletal and Pulmonary Involvement
Nikko Rowe Asuncion Tabliago1, Paula McKenzie2, Caroline Dillon3 & Amelia Morgan4 Show affiliations
- Department of Internal Medicine, Geisinger Medical Center, United States
- Department of Infectious Diseases, Geisinger Medical Center, United States
- Department of Pharmacy, Geisinger Medical Center, United States
- Department of Internal Medicine-Pediatrics, Geisinger Medical Center, United States
American Journal of Infectious Diseases, Volume 18, Issue 3, pp. 46–48 · doi.org/10.3844/ajidsp.2022.46.48
Abstract
Cryptococcus neoformans is an encapsulated yeast that typically causes illness in immunocompromised hosts. Manifestations of the disease include pulmonary, Central Nervous System (CNS), and rare skeletal involvement. Optimal antifungal therapy for skeletal involvement has yet to be established. Here we present a potential antifungal regimen for disseminated cryptococcal disease with skeletal and pulmonary involvement in a patient with Chronic Lymphocytic Leukemia (CLL) on ibrutinib therapy.
Licence and reuse
Open access. This article is licensed under a Creative Commons Attribution 4.0 International Licence (CC BY 4.0), as printed on the article, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original authors and the source. No permission is needed.
How to reuse this articleResponses (0)
About this article
Tabliago, N. R. A., McKenzie, P., Dillon, C. & Morgan, A. (2022). Disseminated Cryptococcal Disease with Skeletal and Pulmonary Involvement. American Journal of Infectious Diseases, 18(3), 46–48. https://doi.org/10.3844/ajidsp.2022.46.48
- Licence
- CC BY 4.0
- Issue
- Volume 18, Issue 3
- Policies
- Editorial independenceUse of generative AIData availabilityAppeals and complaints
- Version
- Version of record